Stentless tricuspid valve replacement.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10585080.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stentless tricuspid valve replacement was performed in a 21-year-old patient with severe destructive tricuspid valve endocarditis resistant to medical therapy. Postoperative recovery was uneventful. Stentless atrioventricular valves are considered an additional treatment option besides stented valves or homograft implantations for severe right-sided endocarditis. Transvalvular hemodynamics are excellent, and right ventricular function can be preserved by suspending the valve at the papillary muscles.
Medical subject headings
- Bioprosthesis
- Endocarditis, Bacterial
- Heart Valve Prosthesis Implantation
- Streptococcal Infections
- Tricuspid Valve Insufficiency